The pathway to commercialization for nanomedicine-Reference-Cited by-同舟云学术

The pathway to commercialization for nanomedicine

Published:2005-03 Issue:1 Volume:1 Page:47-51
ISSN:1549-9634
Container-title:Nanomedicine: Nanotechnology, Biology and Medicine
language:en
Short-container-title:Nanomedicine: Nanotechnology, Biology and Medicine

Author:

Flynn Ted,Wei Chiming

Publisher

Elsevier BV

Subject

Pharmaceutical Science,General Materials Science,Biomedical Engineering,Molecular Medicine,Medicine (miscellaneous),Bioengineering

Reference10 articles.

1. Report on nanotechnology;Roco,2003

2. Espicom Research. White paper. Chichester (UK): Epsicom Consulting; 2004. Available at: www.espicom.com

3. Centers for Medicare and Medicaid Services, Health and Human Services. Annual report on prescription expenditures Washington (DC): US Printing office; 2001.

4. Biotechnology Industry Organization (BIO) 2003 annual report. USA Today, 7 June 2004:1.

5. Biotechnology Industry Organization annual report,2003

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nanomedicine Drug Delivery System;Advances in Novel Formulations for Drug Delivery;2023-02-07

2. Importance of nanomedicine in human health;Green Sustainable Process for Chemical and Environmental Engineering and Science;2023

3. Vasculotoxicity of Metal‐Based Nanoparticles;Toxicology of Nanoparticles and Nanomaterials in Human, Terrestrial and Aquatic Systems;2022-07

4. Nanomedicine: a socio-technical system;Technological Forecasting and Social Change;2021-12

5. Nanoparticle's Significance as Antibacterial Agents & Other Pharmaceutical Applications and Their Limitations: A Critical Review;J PHARM RES INT;2021